School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel; North District Health Office, Ministry of Health, Israel.
Patient Educ Couns. 2013 Nov;93(2):282-8. doi: 10.1016/j.pec.2013.06.014. Epub 2013 Aug 29.
To investigate the association between adherence with oral bisphosphonate treatment, income, health literacy, knowledge, and receiving instructions from a pharmacist or doctor, among Arab postmenopausal women diagnosed with osteoporosis in Israel.
Arab osteoporotic women treated with oral bisphosphonates were interviewed (303 women). The questionnaire included socio-demographic characteristics, knowledge about osteoporosis and health literacy. Adherence was measured by the Medication Possession Ratio (MPR) according to the number of prescription refills registered in the database of Clalit Health Services.
Forty-one percent of the women were adherent according to the MPR. The main predictor of adherence in a multivariate logistic regression was income. Health literacy and knowledge were not associated with adherence after adjustment for income. Neither was the health care provider's counseling regarding the medication.
Lower income seems to be a barrier to adherence with osteoporotic medication, over and above other known barriers. Policy makers should take into account that medication funding may be a barrier to treatment. Practical implications Income may be a major barrier to adherance with osteoporosis medication and calls for attention of practiciner.
研究收入、健康素养、知识以及是否接受药剂师或医生指导与阿拉伯裔绝经后骨质疏松症女性服用口服双膦酸盐治疗的依从性之间的关系。
对接受口服双膦酸盐治疗的阿拉伯裔骨质疏松症女性进行了访谈（303 名女性）。问卷包括社会人口统计学特征、骨质疏松症知识和健康素养。根据 Clalit 健康服务数据库中登记的处方续药数量，采用用药比例（MPR）来衡量依从性。
根据 MPR，41%的女性依从性良好。多变量逻辑回归分析的主要预测因子是收入。调整收入后，健康素养和知识与依从性无关，医疗保健提供者对药物的咨询也没有影响。
与其他已知障碍相比，较低的收入似乎是骨质疏松症药物治疗依从性的障碍。政策制定者应考虑到药物资金可能是治疗的障碍。实际意义收入可能是骨质疏松症药物治疗依从性的主要障碍，需要引起从业者的关注。
